Implantation of bone mesenchymal stem cells overexpressing miRNA‑705 mitigated ischemic brain injury

  • Authors:
    • Meng Ji
    • Wei Wang
    • Shujuan Li
    • Wenli Hu
  • View Affiliations

  • Published online on: September 26, 2017     https://doi.org/10.3892/mmr.2017.7626
  • Pages: 8323-8328
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ischemic brain damage remains the major cause of death and disability worldwide. Bone mesenchymal stem cell (BMSC) transplantation has been identified to serve important roles in cerebral infarction due to its multi‑directional differentiation and proliferative ability. However, the function of miR‑705 combined with BMSCs on ischemic brain injury remains to be fully elucidated. In the present study, an ischemic brain injury mouse model was constructed, and the mice were injected with BMSCs infected by lentiviral particles expressing miR‑705 (BMSCs‑Ad‑miR‑705) to explore the mechanism by which BMSCs‑Ad‑miR‑705 mitigates neurological deficits in ischemic brain damage. In the sham group, no significant neurological injury evaluated via neurological deficit scores was identified, the morphological structure of brain stained with HE was almost normal, and few apoptotic cells were detected by TUNEL assay. However, the PBS group exhibited significant brain damage (P<0.05). BMSCs‑Ad (BMSCs infected with control lentiviral particles) and BMSCs‑Ad‑miR‑705 markedly mitigated neurological injury, suppressed morphological damage and inhibited neuronal apoptosis, however promoted the mRNA levels of brain‑derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) examined by reverse transcription‑quantitative polymerase chain reaction and western blotting. Notably, BMSCs‑Ad‑miR‑705 improved the outcome of BMSCs‑Ad transplantation. These data indicated that BMSCs‑Ad‑miR‑705 promoted the secretion of VEGF and BDNF, suppressed neuronal apoptosis, and stimulated neuronal regeneration, in turn mitigating the impairment of ischemic brain damage.
View Figures
View References

Related Articles

Journal Cover

December-2017
Volume 16 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ji M, Wang W, Li S and Hu W: Implantation of bone mesenchymal stem cells overexpressing miRNA‑705 mitigated ischemic brain injury. Mol Med Rep 16: 8323-8328, 2017.
APA
Ji, M., Wang, W., Li, S., & Hu, W. (2017). Implantation of bone mesenchymal stem cells overexpressing miRNA‑705 mitigated ischemic brain injury. Molecular Medicine Reports, 16, 8323-8328. https://doi.org/10.3892/mmr.2017.7626
MLA
Ji, M., Wang, W., Li, S., Hu, W."Implantation of bone mesenchymal stem cells overexpressing miRNA‑705 mitigated ischemic brain injury". Molecular Medicine Reports 16.6 (2017): 8323-8328.
Chicago
Ji, M., Wang, W., Li, S., Hu, W."Implantation of bone mesenchymal stem cells overexpressing miRNA‑705 mitigated ischemic brain injury". Molecular Medicine Reports 16, no. 6 (2017): 8323-8328. https://doi.org/10.3892/mmr.2017.7626